Difference between revisions of "Team:Bielefeld-CeBiTec"
Line 109: | Line 109: | ||
<p> | <p> | ||
<table style="background-color:transparent; cellspacing=3;"> | <table style="background-color:transparent; cellspacing=3;"> | ||
− | <tr><td colspan="2">< | + | <tr><td colspan="2"><h3 style="color: red">Achievements</h3></td></tr> |
− | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Development of a new cell-free assay named <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/PRIA" target="_blank">Plasmid Repressor Interaction Assay (PRIA)</a><td></tr> | + | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Development of a new cell-free assay named <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/PRIA" target="_blank">Plasmid Repressor Interaction Assay (PRIA)</a>.</td></tr> |
− | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Establishment of a <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/CFPSOverview" target="_blank"> | + | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Establishment of a <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/CFPSOverview" target="_blank">Cell-Free Protein Synthesis (CFPS) system</a> for the iGEM community.</td></tr> |
− | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Demonstration of the | + | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Demonstration of the extensibility of the system by <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/HeavyMetals" target="_blank">several biosensors</a>.</td></tr> |
− | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Construction of a new biosensor for the detection of <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/DateRapeDrugs" target="_blank">date rape drugs</a></td></tr> | + | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Construction of a new biosensor for the detection of <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/DateRapeDrugs" target="_blank">date rape drugs</a>.</td></tr> |
− | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td> | + | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Design and construction of a new biosensor for <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/HeavyMetals" target="_blank">heavy metals (Copper)</a>. </td></tr> |
− | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td> | + | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Development and implementation of a <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Modeling" target="_blank">model</a> for CFPS.</td></tr> |
− | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td> | + | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Starting the <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Practices/DualUse" target="_blank">dual use</a> debate in iGEM including suggestions for new guidelines and discussing the dual use topic on example of <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/DateRapeDrugs" target="_blank">“date rape drugs”</a>.</td></tr> |
<tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Programming of an <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Design" target="_blank">app</a> to quantify fluorescence in pictures generated by our novel filter combination.</td></tr> | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td>Programming of an <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Design" target="_blank">app</a> to quantify fluorescence in pictures generated by our novel filter combination.</td></tr> | ||
− | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td><td> | + | <tr><td><img src="https://static.igem.org/mediawiki/2015/e/e7/Bielefeld-CeBiTec-Checkbox_red.png" class="check" width="40px"></td> |
+ | <td>Providing a 3D printed <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Design" target="_blank">box</a> for fluorescence evaluation. </td></tr> | ||
</table> | </table> | ||
</p> | </p> |
Revision as of 01:19, 19 September 2015
Achievements | |
Development of a new cell-free assay named Plasmid Repressor Interaction Assay (PRIA). | |
Establishment of a Cell-Free Protein Synthesis (CFPS) system for the iGEM community. | |
Demonstration of the extensibility of the system by several biosensors. | |
Construction of a new biosensor for the detection of date rape drugs. | |
Design and construction of a new biosensor for heavy metals (Copper). | |
Development and implementation of a model for CFPS. | |
Starting the dual use debate in iGEM including suggestions for new guidelines and discussing the dual use topic on example of “date rape drugs”. | |
Programming of an app to quantify fluorescence in pictures generated by our novel filter combination. | |
Providing a 3D printed box for fluorescence evaluation. |